Xeris Biopharma Holdings, Inc. (XERS)

5.945 -0.08 (-1.25%) USD  |  NASDAQ  |  Mar 03, 16:00
5.945 0.00 (0.00%) After-Hours: 17:30
More

Xeris Biopharma Holdings Stock Based Compensation (Annual Per Share)

Stock Based Compensation (Annual Per Share) Chart

View Stock Based Compensation (Annual Per Share) for XERS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Based Compensation (Annual Per Share) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Stock Based Compensation (Annual Per Share) Range, Past 5 Years

View Stock Based Compensation (Annual Per Share) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Based Compensation (Annual Per Share) Benchmarks

View Stock Based Compensation (Annual Per Share) Benchmarks
Start Trial
Corcept Therapeutics, Inc. Upgrade
IDEXX Laboratories, Inc. Upgrade
Harrow, Inc. Upgrade
Vir Biotechnology, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade